SEMIFIVE has begun mass production of Bertha, a data center AI inference accelerator developed for fellow South Korean ...
Rentosertib, developed by Insilico Medicine using generative AI, showed consistent biological age reversal across six independent proteomic clocks in a Phase 2a trial.
Insilico’s AI-driven IPF candidate rentosertib shows potential for biological age reversal, as assessed by six proteomic aging clocks: Cambridge, Massachusetts Tuesday, Septembe ...
Insilico Medicine ("Insilico"), a clinical-stage company focused on generative AI-driven drug discovery and development, ...
West-MEC, a public career and technical education school district, has launched a new AI program for its students. They will ...
Spread the loveYou’ve seen the headlines, haven’t you? The whispers about AI taking over jobs, the frantic scramble to learn ...
Researchers from Insilico Medicine and an international group of academic collaborators have applied six independently ...
Developed Proteomic Aging Clocks: Analyzing 12-week longitudinal Olink proteomic data from 42 IPF patients, six aging clock models (including ProtAge, OrganAge, and PAC) independently developed by the ...
Deep in a pine-oak forest in northern Alabama, a 140-foot tower rises above the canopy. Equipped with scientific instruments, ...
Break out of Microsoft-imposed limits with Linux.